Capricor Therapeutics
CAPR
#7985
Rank
S$0.37 B
Marketcap
S$8.24
Share price
-4.36%
Change (1 day)
-59.24%
Change (1 year)

Capricor Therapeutics (CAPR) - Total debt

Total debt on the balance sheet as of September 2025 : S$18.83 Million

According to Capricor Therapeutics 's latest financial reports the company's total debt is S$18.83 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Capricor Therapeutics - Total debt on balance sheet (from 2002 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$1.97 M-33.2%
2023-12-31S$2.95 M-13.96%
2022-12-31S$3.43 M-11.55%
2021-12-31S$3.88 M821.92%
2020-12-31S$0.42 M
2017-12-31N/A-100%
2016-12-31S$20.12 M55.4%
2015-12-31S$12.95 M7.05%
2014-12-31S$12.09 M141.02%
2013-12-31S$5.01 M
2006-12-31S$0.19 M65.47%
2005-12-31S$0.11 M36.28%
2004-12-31S$0.08 M35.08%
2003-12-31S$0.06 M372.55%
2002-12-31S$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cytokinetics
CYTK
S$1.55 B 8,129.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$0.33 M-98.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$59.31 B 314,798.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.55 B 2,845.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$3.39 M-81.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$0.71 M-96.20%๐Ÿ‡บ๐Ÿ‡ธ USA